Hims & Hers Health, Inc., a leading health and wellness platform, has announced plans to introduce at-home lab testing through its platform. The new capability will enable customers to take control of their health with deeper insights and allow providers to access a breadth of data and biomarkers that can help identify risk of disease before it develops.
The company has acquired an at-home lab testing facility, Sigmund NJ LLC (Trybe Labs), which will support at-home blood draws and comprehensive whole body testing. Using a blood lancet, customers will be able to learn more about their hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function, and prostate health.
Providers on the platform will use this information to determine personalized treatment plans for their patients. De-identified lab data will also accelerate the company’s AI developments, including MedMatch by Hims & Hers, to deliver an AI-powered healthcare experience that can provide access to affordable, high-quality care tailored to individuals.
With at-home lab testing, customers will have more information about their health and providers can recommend high-quality, customized treatments backed by precise data for each individual patient. This move aligns with the company’s mission to provide on-demand care with treatments designed specifically for each customer.
Hims & Hers has already established a strong clinical expertise, seamless customer experience, and availability of treatment options customized for individuals. The acquisition of Trybe Labs will further expand its capabilities and enable it to deliver more personalized healthcare solutions.
Source: https://www.businesswire.com/news/home/20250219392487/en/Hims-Hers-Acquires-At-Home-Lab-Testing-Facility-Expanding-Capabilities-to-Ultimately-Include-Affordable-Whole-Body-Testing-for-Subscribers